Clinical Guides
Approach to Skin Rash
A morphology-led, safety-first approach to acute and chronic rashes, integrating emergency recognition, drug and infectious causes, isolation, investigations, biopsy, treatment and referral in Indian practice.
MedNext Academy | 14 min read
Approach to Skin Rash
A morphology-led, safety-first approach to acute and chronic rashes, integrating emergency recognition, drug and infectious causes, isolation, investigations, biopsy, treatment and referral in Indian practice.
Summary
A rash is a physical sign, not a diagnosis. Begin with physiological danger before naming morphology: airway or circulatory compromise suggests anaphylaxis; fever with a non-blanching petechial or purpuric eruption suggests meningococcal disease or another invasive infection; skin pain, mucosal erosions, blistering or detachment after a medicine suggests Stevens-Johnson syndrome or toxic epidermal necrolysis; and pain out of proportion, rapidly spreading oedema, bullae, crepitus or systemic toxicity suggests necrotising soft-tissue infection. These conditions require simultaneous resuscitation, treatment and specialist escalation. Do not wait for a dermatologist, biopsy or a perfectly developed rash.
For a stable patient, describe the primary lesion before scratching, crusting or treatment obscures it: macule, papule, plaque, nodule, wheal, vesicle, bulla, pustule, petechia, purpura or ulcer. Then record colour, surface, border, blanching, tenderness and secondary change. Distribution and configuration often narrow the differential more than a long test panel: flexural or extensor, dermatomal, acral, intertriginous, photo-exposed, palmar-plantar, mucosal, generalised, symmetrical, annular, targetoid or linear. Integrate time course, itch versus pain, fever, contacts, travel, occupation, sexual history, immune status and every new prescription, non-prescription and traditional product.
Most common rashes are diagnosed clinically. Investigations answer a defined question: scraping or microscopy for fungus, swab for infected exudate, blood tests for systemic involvement, biopsy for inflammatory, blistering, vasculitic or neoplastic uncertainty. Treat the cause and barrier, avoid indiscriminate steroid-antifungal combinations, use isolation appropriate to the suspected pathogen, and safety-net evolution. This clinically focused draft has been reviewed by the MedNext Clinical Team and does not replace emergency, infection-control or prescribing protocols.
How Common Is It?
Skin complaints are frequent in primary and emergency care, but prevalence figures are hard to transport across age groups, seasons, climates, occupations and referral settings. Eczema, urticaria, superficial infection, fungal disease, acneiform eruptions and drug reactions are common; severe cutaneous adverse reactions, meningococcal disease and necrotising infection are uncommon but disproportionately dangerous. Base rates should therefore shape the differential without downgrading a painful, rapidly progressive, mucosal or systemically unwell presentation. Common diagnoses can coexist with emergencies, particularly when infection complicates chronic dermatitis.
Burden is not captured by body-surface area alone. Itch disrupts sleep and learning; visible disease can cause stigma; hand or foot involvement can prevent work; genital or mucosal disease can impair nutrition, urination and sexual health. Darker skin can make erythema less conspicuous, so warmth, swelling, tenderness, scale and comparison with unaffected skin become important. Post-inflammatory pigment change may persist after active inflammation resolves and should not be mistaken for treatment failure.
In India, heat, humidity, crowding, occupational exposure, scabies, dermatophytosis, viral exanthems and medicine access influence presentation, but regional stereotypes are unsafe. Patients often try potent topical corticosteroid combinations before assessment, altering the border of tinea or worsening infection. A rational approach uses morphology and distribution, asks what has already been applied, and reserves tests for uncertainty or severity. The clinician's epidemiological task is to recognise the pattern of transmissibility, exposure and immune status while retaining a low threshold for emergency escalation when physiology or skin pain is concerning.
Risk Factors
Risk factors should be linked to mechanism. Atopy, dry skin, irritants, wet work, detergents and occupational gloves support eczematous disease. Close contact, shared bedding, institutional living and household itch support scabies. Humidity, occlusion, diabetes, obesity, communal bathing and prior topical steroid use can increase or disguise dermatophyte infection. New sexual exposure changes the differential for secondary syphilis, acute HIV and disseminated infection; take a confidential, non-judgemental history and obtain consent for testing. Vaccination, travel, outbreak contact and immune status matter for measles, varicella and other exanthems.
Drug causality depends on a complete timeline. Record generic and brand names, start and stop dates, dose escalation, intermittent use and the indication for every antibiotic, anticonvulsant, analgesic, antitubercular, antiretroviral, supplement and traditional remedy. Immediate urticaria or anaphylaxis may occur soon after exposure; morbilliform eruptions often appear days later; DRESS can emerge weeks after initiation; and SJS/TEN typically combines painful rash, systemic symptoms and mucosal or epidermal injury. Previous tolerance does not exclude allergy, but a temporal association alone does not prove causation.
Severe or atypical infection is more likely with diabetes, peripheral vascular disease, lymphoedema, malnutrition, HIV, chemotherapy, systemic corticosteroids, neutropenia or a disrupted skin barrier. Autoimmune and vasculitic disease becomes more plausible with photosensitivity, arthritis, renal findings, neuropathy, haematuria or recurrent oral or genital ulcers. Pregnancy changes both differential and treatment safety. Ask about family history of psoriasis or blistering disease, personal autoimmune history and skin cancer risk. Risk factors refine probability; morphology, physiological state and trajectory decide urgency.
Diagnosis
History
Define the first lesion, exact onset, evolution, spread, itch, pain, skin tenderness, fever and mucosal symptoms. Ask whether lesions appear and vanish within hours, remain fixed, blister, bruise or fail to blanch. Establish new medicines during at least the preceding two months, infections, vaccines, food or insect exposure, travel, sick contacts, animals, occupation, sexual exposure and household itch. Ask about breathlessness, throat tightness, dizziness, headache, photophobia, joint pain, abdominal pain, urine change and pregnancy. Photograph progression with consent and record treatments already tried.
Examination
Assess airway, breathing, circulation, temperature and mental state before the skin. Expose adequately while preserving dignity. Name the primary lesion, measure it, test blanching with appropriate pressure and describe surface, border, colour, tenderness and secondary excoriation, scale, crust or ulceration. Map distribution, symmetry, dermatomes, flexures, extensor surfaces, scalp, nails, palms, soles and interspaces. Inspect oral, ocular and genital mucosa when clinically relevant with consent and a chaperone. Look for facial oedema, lymphadenopathy, hepatosplenomegaly, meningism, arthritis, neuropathy and signs of organ dysfunction.
Investigations
Do not order a generic rash panel. Use skin scraping or microscopy when fungal infection is uncertain; bacterial swab when purulent, crusted or treatment-resistant infection will change therapy; and viral PCR from an appropriate lesion when confirmation changes isolation or antiviral management. Full blood count, renal and liver profiles, inflammatory markers, urinalysis, cultures, serology or HIV testing follow the suspected systemic process and consent. Biopsy an appropriate fresh lesion, sometimes with paired perilesional tissue for direct immunofluorescence, after discussing the question with dermatology or pathology. In suspected SJS/TEN, vasculitis or necrotising infection, investigation must not delay emergency treatment.
Differential Diagnosis
An itchy, poorly demarcated, scaly eruption favours eczema; sharply demarcated extensor plaques with silvery scale and nail change suggest psoriasis. Annular plaques with an active scaly border suggest dermatophyte infection, but previous topical steroid may produce tinea incognito. Transient wheals that migrate and resolve within twenty-four hours support urticaria; fixed urticarial lesions lasting longer, bruising or systemic symptoms suggest vasculitis or another mimic. Vesicles in a dermatomal distribution suggest herpes zoster, while generalised vesicles at different stages with fever suggest varicella. Honey-coloured crust supports impetigo; warmth, pain and spreading oedema support cellulitis.
A morbilliform drug eruption competes with viral exanthem. Timing, systemic features, mucosal involvement, eosinophilia, facial oedema, lymph nodes and organ injury refine the distinction. Painful targetoid or purpuric lesions with blistering, mucosal erosions or detachment raise SJS/TEN. Fever plus petechiae or ecchymoses demands immediate assessment for meningococcal sepsis and other invasive infection, while palpable purpura with renal, abdominal, joint or neurological features suggests small-vessel vasculitis. Do not call every non-blanching lesion meningococcal or every drug-associated rash an allergy; do not allow this uncertainty to delay treatment of a toxic patient.
Autoimmune possibilities include cutaneous lupus, dermatomyositis, bullous pemphigoid and pemphigus. Secondary syphilis can involve palms and soles; scabies favours finger webs, wrists, waist and genital areas and often affects contacts. Phototoxic, contact, arthropod and occupational eruptions depend on distribution. Skin cancer may resemble a persistent plaque, ulcer or nodule. In richly pigmented skin, inflammation may appear violaceous, grey or dark brown rather than bright red. Diagnostic confidence should be calibrated, with evolution reviewed rather than forcing an early label.
Management
Resuscitate anaphylaxis using the current emergency protocol with intramuscular adrenaline as first-line treatment, airway and circulatory support, observation and allergy follow-up; antihistamines do not replace adrenaline. For fever with rapidly evolving non-blanching rash or suspected meningococcal disease, initiate sepsis care, empirical antibiotics and droplet precautions without waiting for rash progression. Suspected SJS/TEN requires immediate withdrawal of likely culprit medicines, supportive skin-failure care and urgent dermatology, critical-care and ophthalmology involvement. Suspected necrotising infection requires resuscitation, broad empirical antimicrobials and immediate surgical assessment; imaging must not delay source control when clinical suspicion is high.
Stable treatment is diagnosis-specific. Restore the barrier with bland emollient, appropriate washing and trigger avoidance in eczema, adding a correctly potent topical corticosteroid for the correct site and duration when indicated. Use antifungal monotherapy and adherence counselling for dermatophyte infection; avoid unlabelled steroid-antifungal-antibacterial combinations. Treat scabies with the locally recommended agent and simultaneous contact and environmental measures. Urticaria without anaphylaxis usually begins with a non-sedating antihistamine. Cellulitis requires antimicrobial selection based on severity, site, allergy, local resistance and stewardship, plus reassessment if spread or systemic illness develops.
Explain what improvement should look like and when to stop or step down. Photograph or outline a spreading infection with consent, but do not use a pen line as the only monitoring tool. Review uncertain rashes early because morphology evolves. Protect broken skin, manage pain and hydration, and avoid picking. When infection is plausible, choose standard, contact, droplet or airborne precautions by syndrome and local policy. Treating itch alone is inadequate when the cause remains dangerous or transmissible.
Prescribing Information
Topical treatment is active prescribing. Match corticosteroid potency to diagnosis, anatomical site, age, extent and duration; thin skin, face, flexures and genital areas absorb more and are vulnerable to atrophy. Explain fingertip-unit or local quantity guidance, apply emollient generously, and review response. Potent steroids can suppress or modify dermatophyte infection, producing tinea incognito. Combination creams containing potent corticosteroid, antifungal and antibacterial agents encourage misuse and may delay diagnosis. Calcineurin inhibitors, phototherapy or systemic immunomodulation require indication-specific counselling and monitoring.
Antihistamines may reduce urticarial itch but are not treatment for airway compromise or shock. Sedating products impair driving and work; dose adjustment or avoidance may be required with comorbidity and interacting medicines. Antibiotics should follow the current Indian or institutional antimicrobial policy, renal and hepatic function, pregnancy, allergy history and likely pathogen. Do not prescribe antibiotics for a non-infected inflammatory rash. Antivirals for herpes zoster or varicella depend on age, immune status, site, severity and time since onset.
When a drug reaction is suspected, stop the likely culprit when clinically safe, document drug, formulation, timing, morphology and severity, and identify essential medicines needing specialist substitution. Do not perform casual rechallenge after anaphylaxis, DRESS, SJS/TEN or another severe reaction. Systemic corticosteroids can worsen infection, hyperglycaemia and diagnostic uncertainty and should not be used as a universal rash remedy. In pregnancy, breastfeeding, infancy, frailty, renal or liver disease and immunosuppression, verify each product against current prescribing information. Evidence for systemic therapies in SJS/TEN and several rare inflammatory eruptions remains limited or heterogeneous; specialist protocols and supportive care govern decisions.
When to Refer
Send immediately to emergency care for airway swelling, wheeze, hypotension or collapse; fever with non-blanching rash or sepsis; painful dusky skin, mucosal erosion, blistering or detachment; rapidly spreading painful swelling, bullae, crepitus or systemic toxicity; extensive burns-like skin failure; acute ocular involvement; or a rash with severe organ dysfunction. Suspected SJS/TEN requires a multidisciplinary service capable of skin-failure, eye, airway, fluid and critical-care management. Suspected necrotising infection needs surgeons now, not a routine dermatology appointment. Initiate stabilisation, antimicrobials or adrenaline as indicated while transfer is organised.
Urgent dermatology or medical assessment is appropriate for widespread erythroderma, extensive blistering, palpable purpura with systemic features, rapidly progressive disease, suspected DRESS, immunosuppression with an atypical eruption, severe infection, diagnostic uncertainty affecting an essential medicine, or failure of appropriate first-line treatment. Eye pain, photophobia or visual change requires ophthalmology. Pregnant patients with a new widespread or blistering eruption may need coordinated obstetric and dermatology care. Suspected measles, varicella or meningococcal disease also requires infection-control and public-health notification according to current local rules.
Routine referral is reasonable for chronic disease impairing sleep, work or schooling; recurrent urticaria; suspected contact allergy needing patch testing; uncertain pigmentary disease; scarring alopecia; nail disease; or a persistent changing, bleeding or non-healing lesion. Biopsy referral should state the differential and select a fresh representative lesion; direct immunofluorescence often needs separate perilesional tissue in the correct medium. Send photographs only with consent and secure handling. Continue treatment and safety-netting while the patient waits, and name who will review results.
Red Flags
Anaphylaxis is a clinical emergency defined by rapid airway, breathing or circulatory compromise, often with urticaria, flushing or angioedema but sometimes without prominent skin signs. Give intramuscular adrenaline according to protocol; do not delay for antihistamines, corticosteroids or serum tryptase. Fever with petechiae or purpura that do not blanch, especially with headache, neck stiffness, limb pain, cold extremities, confusion or shock, is meningococcal disease until urgently assessed. A rash may be absent early, so systemic toxicity carries more weight than waiting for a textbook pattern.
Skin pain is a high-value warning. Painful erythema, dusky targetoid lesions, mucosal erosions, blistering or epidermal detachment after a newly started medicine suggests SJS/TEN. Facial oedema, fever, lymphadenopathy, eosinophilia or liver and kidney injury suggests DRESS. Rapidly advancing swelling, severe pain out of proportion, anaesthesia, bullae, skin discoloration, crepitus or haemodynamic instability suggests necrotising infection. Normal early imaging or modest inflammatory markers do not safely exclude it when the clinical trajectory is concerning.
Other urgent signals include extensive erythroderma with temperature or fluid disturbance, purpura with renal or neurological involvement, eye pain or corneal symptoms, widespread lesions in an immunocompromised person, and blistering in pregnancy or infancy. Document mucosa, body-surface extent, vital signs, urine output and progression. Do not prescribe systemic steroid and review in a week for an undiagnosed toxic eruption. Safety-net stable patients for fever, breathlessness, dizziness, new mucosal pain, blistering, non-blanching lesions, rapidly increasing pain or spread, reduced urine or inability to drink.
Indian Clinical Context
India's climate, housing, occupations and medicine-access patterns shape rash care. Scabies, dermatophytosis, impetigo, contact dermatitis and arthropod reactions may cluster within households or workplaces. Over-the-counter fixed-dose combination creams containing potent corticosteroids can suppress inflammation while allowing fungal infection to extend. Ask patients to bring tubes, strips or photographs and explain the mechanism without blame. Use microscopy or an appropriate therapeutic trial when tinea is uncertain rather than escalating steroid potency. Household treatment and laundering instructions must be feasible when water, privacy or replacement bedding is limited.
Transmissible rash requires triage before a crowded waiting room. A febrile patient with cough, coryza and a generalised maculopapular eruption may need airborne precautions for suspected measles; a generalised vesicular eruption may require airborne and contact precautions for varicella; suspected meningococcal disease requires droplet precautions alongside urgent treatment. Apply current national, state and institutional surveillance and notification rules, because outbreak definitions change. Isolation should be based on the suspected syndrome, not on fear of all visible skin disease.
In darker skin, erythema may be subtle; assess warmth, tenderness, oedema, scale and colour change in good light and compare sites. Provide instructions in the patient's language and account for cost, travel and medication availability. HIV, tuberculosis therapy, antiepileptic medicines and antimicrobial exposure change drug-reaction risk and interaction review, but diagnosis still requires a timeline and examination. Where dermatology or histopathology is distant, photograph with consent, discuss biopsy handling before sampling and arrange a named result pathway. Do not let inability to obtain a biopsy delay resuscitation, culprit-drug withdrawal or surgical referral.
NMC Competency Mapping
This approach integrates NMC competencies in Dermatology, Medicine, Paediatrics, Pharmacology, Microbiology, Emergency Medicine and Community Medicine. A learner should describe a primary and secondary lesion accurately, map its distribution, inspect mucosa, assess blanching and recognise when skin colour alters the appearance of erythema. They should construct a mechanism-based differential spanning inflammatory, infectious, drug-related, autoimmune, vascular and neoplastic disease, then choose a targeted bedside test, microbiology sample or biopsy rather than requesting an indiscriminate panel.
Emergency competence includes recognising and beginning treatment for anaphylaxis, meningococcal sepsis, SJS/TEN and necrotising soft-tissue infection. Pharmacology outcomes include topical steroid potency, rational antimicrobial use, adverse drug reaction timelines, severe-reaction documentation and pregnancy or organ-function safety. Microbiology and Community Medicine contribute correct specimen collection, standard and transmission-based precautions, contact management and notification. Learners must understand that a contagious exanthem, inflammatory rash and severe drug reaction can look similar early and that isolation or resuscitation may precede diagnostic certainty.
Workplace assessment can include a complete morphology note, body map, consented photograph, skin scraping, drug timeline, infection-control decision and referral handover. Case discussions should test a non-blanching rash with fever, a painful mucosal eruption after anticonvulsant initiation, steroid-modified tinea, palpable purpura with haematuria and chronic eczema with secondary infection. Competence is safe uncertainty: stating the leading diagnosis, dangerous alternatives, evidence limits, plan for evolution and exact return precautions. Naming a rash from an image alone is insufficient clinical performance.
Key Exam Pearls for NEET PG
Describe before diagnosing: primary lesion, secondary change, distribution and configuration. Macules and papules are flat and raised lesions under one centimetre respectively; plaques are raised and broader; vesicles contain clear fluid and bullae are larger; petechiae and purpura represent non-blanching blood extravasation. Wheals are oedematous and transient. Palpable purpura suggests small-vessel inflammation, while non-palpable petechiae with fever can signal invasive infection. In darker skin, erythema may appear violaceous, grey or brown and must be supported by palpation and comparison.
Anaphylaxis is treated first with intramuscular adrenaline, not antihistamine. Fever plus a rapidly progressive non-blanching rash requires immediate sepsis and meningococcal action. SJS/TEN features skin pain, fever, dusky or targetoid lesions, mucosal erosion and epidermal detachment; stop the likely culprit and obtain urgent multidisciplinary care. DRESS more often combines a delayed drug eruption with facial oedema, lymphadenopathy, eosinophilia and internal-organ injury. Necrotising infection is suggested by pain out of proportion, rapid spread, bullae, anaesthesia, crepitus or toxicity and needs immediate surgery.
An active scaly annular edge suggests tinea; potent topical steroid can obscure it. Transient individual wheals lasting less than a day support urticaria, whereas persistent bruising lesions suggest urticarial vasculitis. Biopsy selection depends on the question: routine histology samples a representative active lesion, while immunobullous disease often requires separate perilesional tissue for direct immunofluorescence. Measles calls for airborne precautions, varicella for airborne plus contact precautions, and suspected meningococcal disease for droplet precautions under local policy. Evidence for many rare-rash therapies is limited; exams and practice should prioritise stabilisation, culprit withdrawal and correct referral.
Frequently Asked Questions
Which rash features require emergency treatment before a definite diagnosis?
Treat airway, breathing or circulatory compromise as anaphylaxis; fever with rapidly evolving non-blanching purpura as possible invasive meningococcal disease; painful mucosal blistering or detachment after a medicine as possible SJS/TEN; and rapidly spreading pain, oedema, bullae or toxicity as possible necrotising infection. Start the relevant resuscitation, isolation, antimicrobials, culprit withdrawal or surgical escalation while diagnostic work continues.
How should a clinician document morphology and distribution in a skin rash?
Name the primary lesion, then record size, colour, border, surface, blanching, tenderness and secondary scale, crust, excoriation or ulceration. Map symmetry and sites including flexures, extensor surfaces, scalp, nails, palms, soles, interspaces and relevant mucosa. Describe configuration such as annular, targetoid, linear or dermatomal. A consented photograph and body map help compare evolution but do not replace examination.
When are skin scraping, swab or biopsy useful in an undiagnosed rash?
Use scraping or microscopy when a fungal diagnosis is uncertain, and swab purulent or crusted lesions when microbiology will change antimicrobial choice. Biopsy is useful for persistent diagnostic uncertainty, vasculitis, blistering disease, inflammatory dermatosis or suspected neoplasia. Discuss lesion selection and transport with dermatology or pathology; direct immunofluorescence often needs separate perilesional tissue. None of these tests should delay emergency treatment.
Should every patient with a suspected infectious rash be isolated in the same way?
No. Precautions follow the suspected transmission route and local policy. A febrile maculopapular rash with cough and coryza may require airborne precautions for measles; generalised vesicles may require airborne plus contact precautions for varicella; and suspected meningococcal disease requires droplet precautions. Standard precautions remain universal. Reassess when test results or clinical evolution change the suspected cause and involve infection-control or public-health teams early.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic